Functional Characterization of Secreted Aspartyl Proteases in Candida parapsilosis

. 2019 Aug 21 ; 4 (4) : . [epub] 20190821

Jazyk angličtina Země Spojené státy americké Médium electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid31434748

Candida parapsilosis is an emerging non-albicans Candida species that largely affects low-birth-weight infants and immunocompromised patients. Fungal pathogenesis is promoted by the dynamic expression of diverse virulence factors, with secreted proteolytic enzymes being linked to the establishment and progression of disease. Although secreted aspartyl proteases (Sap) are critical for Candida albicans pathogenicity, their role in C. parapsilosis is poorly elucidated. In the present study, we aimed to examine the contribution of C. parapsilosisSAPP genes SAPP1, SAPP2, and SAPP3 to the virulence of the species. Our results indicate that SAPP1 and SAPP2, but not SAPP3, influence adhesion, host cell damage, phagosome-lysosome maturation, phagocytosis, killing capacity, and cytokine secretion by human peripheral blood-derived macrophages. Purified Sapp1p and Sapp2p were also shown to efficiently cleave host complement component 3b (C3b) and C4b proteins and complement regulator factor H. Additionally, Sapp2p was able to cleave factor H-related protein 5 (FHR-5). Altogether, these data demonstrate the diverse, significant contributions that SAPP1 and SAPP2 make to the establishment and progression of disease by C. parapsilosis through enabling the attachment of the yeast cells to mammalian cells and modulating macrophage biology and disruption of the complement cascade.IMPORTANCE Aspartyl proteases are present in various organisms and, among virulent species, are considered major virulence factors. Host tissue and cell damage, hijacking of immune responses, and hiding from innate immune cells are the most common behaviors of fungal secreted proteases enabling pathogen survival and invasion. C. parapsilosis, an opportunistic human-pathogenic fungus mainly threatening low-birth weight neonates and children, possesses three SAPP protein-encoding genes that could contribute to the invasiveness of the species. Our results suggest that SAPP1 and SAPP2, but not SAPP3, influence host evasion by regulating cell damage, phagocytosis, phagosome-lysosome maturation, killing, and cytokine secretion. Furthermore, SAPP1 and SAPP2 also effectively contribute to complement evasion.

Zobrazit více v PubMed

Falagas ME, Roussos N, Vardakas KZ. 2010. Relative frequency of albicans and the various non-albicans PubMed DOI

Lockhart SR. 2014. Current epidemiology of DOI

Tóth R, Nosek J, Mora-Montes HM, Gabaldon T, Bliss JM, Nosanchuk JD, Turner SA, Butler G, Vágvölgyi C, Gácser A. 2019. PubMed PMC

van Asbeck EC, Clemons KV, Stevens DA. 2009. PubMed DOI

Gow NAR, van de Veerdonk FL, Brown AJP, Netea MG. 2012. PubMed DOI PMC

Naglik JR, Richardson JP, Moyes DL. 2014. PubMed DOI PMC

Araújo D, Henriques M, Silva S. 2017. Portrait of PubMed DOI

Jaskolski M, Miller M, Mohana Rao JK, Gustchina A, Wlodawer A. 2015. Elucidation of the structure of retroviral proteases: a reminiscence. FEBS J 282:4059–4066. doi: 10.1111/febs.13397. PubMed DOI PMC

Dutton LC, Jenkinson HF, Lamont RJ, Nobbs AH. 2016. Role of PubMed DOI PMC

Wu H, Downs D, Ghosh K, Ghosh AK, Staib P, Monod M, Tang J. 2013. PubMed DOI PMC

Naglik JR, Challacombe SJ, Hube B. 2003. PubMed DOI PMC

Pietrella D, Pandey N, Gabrielli E, Pericolini E, Perito S, Kasper L, Bistoni F, Cassone A, Hube B, Vecchiarelli A. 2013. Secreted aspartic proteases of PubMed DOI

Rasheed M, Battu A, Kaur R. 2018. Aspartyl proteases in PubMed DOI PMC

Rapala-Kozik M, Bochenska O, Zajac D, Karkowska-Kuleta J, Gogol M, Zawrotniak M, Kozik A. 2018. Extracellular proteinases of PubMed DOI

Horváth P, Nosanchuk JD, Hamari Z, Vágvölgyi C, Gácser A. 2012. The identification of gene duplication and the role of secreted aspartyl proteinase 1 in PubMed DOI

Silva S, Henriques M, Oliveira R, Azeredo J, Malic S, Hooper SJ, Williams DW. 2009. Characterization of PubMed DOI

Williams DW, Jordan RPC, Wei X, Alves CT, Wise P, Wilson MJ, Lewis M. 2013. Interactions of Candida albicans with host epithelial surfaces. J Oral Microbiol 5. doi: 10.3402/jom.v5i0.2243. PubMed DOI PMC

Verma AH, Richardson JP, Zhou C, Coleman BM, Moyes DL, Ho J, Huppler AR, Ramani K, Mcgeachy MJ, Mufazalov IA, Waisman A, Kane LP, Biswas PS, Hube B, Naglik JR, Gaffen SL. 2017. Oral epithelial cells orchestrate innate type 17 responses to PubMed DOI PMC

Drummond RA, Gaffen SL, Hise AG, Brown GD. 2015. Innate defense against fungal pathogens. Cold Spring Harb Perspect Med 5:a019620. doi: 10.1101/cshperspect.a019620. PubMed DOI PMC

Tucey TM, Verma J, Harrison PF, Snelgrove SL, Lo TL, Scherer AK, Barugahare AA, Powell DR, Wheeler RT, Hickey MJ, Beilharz TH, Naderer T, Traven A. 2018. Glucose homeostasis is important for immune cell viability during PubMed DOI PMC

Kasper L, König A, Koenig P, Gresnigt MS, Westman J, Drummond RA, Lionakis MS, Groß O, Ruland J, Naglik JR, Hube B. 2018. The fungal peptide toxin Candidalysin activates the NLRP3 inflammasome and causes cytolysis in mononuclear phagocytes. Nat Commun 9:4260. doi: 10.1038/s41467-018-06607-1. PubMed DOI PMC

Brown AJP, Gow NAR, Warris A, Brown GD. 2019. Memory in fungal pathogens promotes immune evasion, colonisation, and infection. Trends Microbiol 27:219–230. doi: 10.1016/j.tim.2018.11.001. PubMed DOI

Lubbers R, van Essen MF, van Kooten C, Trouw LA. 2017. Production of complement components by cells of the immune system. Clin Exp Immunol 188:183–194. doi: 10.1111/cei.12952. PubMed DOI PMC

Rosbjerg A, Genster N, Pilely K, Garred P. 2017. Evasion mechanisms used by pathogens to escape the lectin complement pathway. Front Microbiol 8:1–7. doi: 10.3389/fmicb.2017.00868. PubMed DOI PMC

Karkowska-Kuleta J, Zajac D, Bochenska O, Kozik A. 2015. Surfaceome of pathogenic yeasts, PubMed DOI

Meri T, Hartmann A, Lenk D, Eck R, Würzner R, Hellwage J, Meri S, Zipfel PF. 2002. The yeast PubMed DOI PMC

Bryan AM, Del Poeta M. 2016. Secretory aspartyl proteinases induce neutrophil chemotaxis PubMed DOI PMC

Borg-von Zepelin M, Beggah S, Boggian K, Sanglard D, Monod M. 1998. The expression of the secreted aspartyl proteinases SapIV to SapVI from PubMed DOI

Dunkel N, Morschhäuser J. 2011. Loss of heterozygosity at an unlinked genomic locus is responsible for the phenotype of a PubMed DOI PMC

Vylkova S, Lorenz MC. 2014. Modulation of phagosomal pH by PubMed DOI PMC

Svoboda E, Schneider AE, Sándor N, Lermann U, Staib P, Kremlitzka M, Bajtay Z, Barz D, Erdei A, Józsi M. 2015. Secreted aspartic protease 2 of PubMed DOI

Poltermann S, Kunert A, Von Der Heide M, Eck R, Hartmann A, Zipfel PF. 2007. Gpm1p is a factor H-, FHL-1, and plasminogen-binding surface protein of PubMed DOI

Gow NAR, Hube B. 2012. Importance of the PubMed DOI

Joo MY, Shin JH, Jang HC, Song ES, Kee SJ, Shin MG, Suh SP, Ryang DW. 2013. Expression of SAPV and SAPIX in PubMed DOI

Ghannoum M, Elteen KA. 1986. Correlative relationship between proteinase production, adherence and pathogenicity of various strains of PubMed DOI

Navarro-Arias MJ, Defosse TA, Dementhon K, Csonka K, Mellado-Mojica E, Dias Valério A, González-Hernández RJ, Courdavault V, Clastre M, Hernández NV, Pérez-García LA, Singh DK, Vizler C, Gácser A, Almeida RS, Noël T, López MG, Papon N, Mora-Montes HM. 2016. Disruption of protein mannosylation affects PubMed DOI PMC

Kumar R, Saraswat D, Tati S, Edgerton M. 2015. Novel aggregation properties of PubMed DOI PMC

Watts HJ, Cheah FS, Hube B, Sanglard D, Gow NA. 1998. Altered adherence in strains of PubMed DOI

Albrecht A, Felk A, Pichova I, Naglik JR, Schaller M, De Groot P, MacCallum D, Odds FC, Schäfer W, Klis F, Monod M, Hube B. 2006. Glycosylphosphatidylinositol-anchored proteases of PubMed DOI

Palmeira VF, Kneipp LF, Alviano CS, dos Santos A. 2006. Secretory aspartyl peptidase activity from mycelia of the human fungal pathogen Fonsecaea pedrosoi: effect of HIV aspartyl proteolytic inhibitors. Res Microbiol 157:819–826. doi: 10.1016/j.resmic.2006.07.003. PubMed DOI

Noris M, Remuzzi G. 2013. Overview of complement activation and regulation. Semin Nephrol 33:479–492. doi: 10.1016/j.semnephrol.2013.08.001. PubMed DOI PMC

Arbore G, Kemper C, Kolev M. 2017. Intracellular complement − the complosome − in immune cell regulation. Mol Immunol 89:2–9. doi: 10.1016/j.molimm.2017.05.012. PubMed DOI PMC

Józsi M, Tortajada A, Uzonyi B, Goicoechea de Jorge E, Rodríguez de Córdoba S. 2015. Factor H-related proteins determine complement-activating surfaces. Trends Immunol 36:374–384. doi: 10.1016/j.it.2015.04.008. PubMed DOI

Józsi M. 2017. Factor H family proteins in complement evasion of microorganisms. Front Immunol 8:571. doi: 10.3389/fimmu.2017.00571. PubMed DOI PMC

Skerka C, Chen Q, Fremeaux-Bacchi V, Roumenina LT. 2013. Complement factor H related proteins (CFHRs). Mol Immunol 56:170–180. doi: 10.1016/j.molimm.2013.06.001. PubMed DOI

Sánchez-Corral P, Pouw RB, López-Trascasa M, Józsi M. 2018. Self-damage caused by dysregulation of the complement alternative pathway: relevance of the factor H protein family. Front Immunol 9:1607. doi: 10.3389/fimmu.2018.01607. PubMed DOI PMC

Zwarthoff SA, Berends ETM, Mol S, Ruyken M, Aerts PC, Józsi M, de Haas CJC, Rooijakkers SHM, Gorham RD. 2018. Functional characterization of alternative and classical pathway C3/C5 convertase activity and inhibition using purified models. Front Immunol 9:1691. doi: 10.3389/fimmu.2018.01691. PubMed DOI PMC

McRae JL, Duthy TG, Griggs KM, Ormsby RJ, Cowan PJ, Cromer BA, McKinstry WJ, Parker MW, Murphy BF, Gordon DL. 2005. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein. J Immunol 174:6250–6256. doi: 10.4049/jimmunol.174.10.6250. PubMed DOI

Hellwage J, Jokiranta TS, Koistinen V, Vaarala O, Meri S, Zipfel PF. 1999. Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparin. FEBS Lett 462:345–352. doi: 10.1016/s0014-5793(99)01554-9. PubMed DOI

Heinen S, Hartmann A, Lauer N, Wiehl U, Dahse HM, Schirmer S, Gropp K, Enghardt T, Wallich R, Hälbich S, Mihlan M, Schlötzer-Schrehardt U, Zipfel PF, Skerka C. 2009. Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood 114:2439–2447. doi: 10.1182/blood-2009-02-205641. PubMed DOI

Eberhardt HU, Buhlmann D, Hortschansky P, Chen Q, Böhm S, Kemper MJ, Wallich R, Hartmann A, Hallström T, Zipfel PF, Skerka C. 2013. Human factor H-related protein 2 (CFHR2) regulates complement activation. PLoS One 8:e78617. doi: 10.1371/journal.pone.0078617. PubMed DOI PMC

Hebecker M, Józsi M. 2012. Factor H-related protein 4 activates complement by serving as a platform for the assembly of alternative pathway C3 convertase via its interaction with C3b protein. J Biol Chem 287:19528–19536. doi: 10.1074/jbc.M112.364471. PubMed DOI PMC

Csincsi ÁI, Szabó Z, Bánlaki Z, Uzonyi B, Cserhalmi M, Kárpáti É, Tortajada A, Caesar JJE, Prohászka Z, Jokiranta TS, Lea SM, Rodríguez de Córdoba S, Józsi M. 2017. FHR-1 binds to C-reactive protein and enhances rather than inhibits complement activation. J Immunol 199:292–303. doi: 10.4049/jimmunol.1600483. PubMed DOI

Goicoechea de Jorge E, Lea SM, Daigo K, Caesar JJE, Csincsi ÁI, Zöldi M, Pickering MC, Józsi M, Kopp A, Hamakubo T, Bánlaki Z, Uzonyi B, Hebecker M. 2015. Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation. J Immunol 194:4963–4973. doi: 10.4049/jimmunol.1403121. PubMed DOI PMC

Tóth R, Cabral V, Thuer E, Bohner F, Németh T, Papp C, Nimrichter L, Molnár G, Vágvölgyi C, Gabaldón T, Nosanchuk JD, Gácser A. 2018. Investigation of PubMed DOI PMC

Richardson JP, Ho J, Naglik JR. 2018. Candida-epithelial interactions. J Fungi (Basel) 4. doi: 10.3390/jof4010022. PubMed DOI PMC

Pietrella D, Rachini A, Pandey N, Schild L, Netea M, Bistoni F, Hube B, Vecchiarelli A. 2010. The inflammatory response induced by aspartic proteases of Candida albicans is independent of proteolytic activity. Infect Immun 78:4754–4762. doi: 10.1128/IAI.00789-10. PubMed DOI PMC

Trevijano-Contador N, Zaragoza O. 2018. Immune response of PubMed DOI PMC

Gácser A, Trofa D, Schäfer W, Nosanchuk JD. 2007. Targeted gene deletion in PubMed DOI PMC

Németh T, Tóth A, Szenzenstein J, Horváth P, Nosanchuk JD, Grózer Z, Tóth R, Papp C, Hamari Z, Vágvölgyi C, Gácser A. 2013. Characterization of virulence properties in the PubMed DOI PMC

Richardson JP, Mogavero S, Moyes DL, Blagojevic M, Krüger T, Verma AH, Coleman BM, De La Cruz Diaz J, Schulz D, Ponde NO, Carrano G, Kniemeyer O, Wilson D, Bader O, Enoiu SI, Ho J, Kichik N, Gaffen SL, Hube B, Naglik JR. 2018. Processing of PubMed DOI PMC

Tóth A, Németh T, Csonka K, Horváth P, Vágvölgyi C, Vizler C, Nosanchuk JD, Gácser A. 2014. Secreted PubMed DOI PMC

Chakraborty T, Thuer E, Heijink M, Tóth R, Bodai L, Vágvölgyi C, Giera M, Gabaldón T, Gácser A. 2018. Eicosanoid biosynthesis influences the virulence of PubMed DOI PMC

Dostál J, Brynda J, Hrusková-Heidingsfeldová O, Sieglová I, Pichová I, Rezácová P. 2009. The crystal structure of the secreted aspartic protease 1 from PubMed

Hrus O, Hradilek M, Majer F, Havlı J. 2009. Two aspartic proteinases secreted by the pathogenic yeast PubMed

Kopp A, Strobel S, Tortajada A, Rodríguez de Córdoba S, Sánchez-Corral P, Prohászka Z, López-Trascasa M, Józsi M. 2012. Atypical hemolytic uremic syndrome-associated variants and autoantibodies impair binding of factor H and factor H-related protein 1 to pentraxin 3. J Immunol 189:1858–1867. doi: 10.4049/jimmunol.1200357. PubMed DOI

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...